Dr Reddys Laboratories (RDY) Debt to Equity (2016 - 2025)
Historic Debt to Equity for Dr Reddys Laboratories (RDY) over the last 14 years, with Q3 2025 value amounting to $63.22.
- Dr Reddys Laboratories' Debt to Equity changed N/A to $63.22 in Q3 2025 from the same period last year, while for Sep 2025 it was $63.22, marking a year-over-year change of. This contributed to the annual value of $0.14 for FY2025, which is 10492.99% up from last year.
- Dr Reddys Laboratories' Debt to Equity amounted to $63.22 in Q3 2025.
- Over the past 5 years, Dr Reddys Laboratories' Debt to Equity peaked at $63.22 during Q3 2025, and registered a low of $0.0 during Q2 2022.
- Its 5-year average for Debt to Equity is $24.5, with a median of $15.86 in 2023.
- Its Debt to Equity has fluctuated over the past 5 years, first soared by 3892123401.65% in 2023, then tumbled by 9935.9% in 2024.
- Quarter analysis of 5 years shows Dr Reddys Laboratories' Debt to Equity stood at $35.38 in 2021, then tumbled by 100.0% to $0.0 in 2022, then skyrocketed by 12106589927.17% to $15.86 in 2023, then crashed by 99.58% to $0.07 in 2024, then surged by 94686.94% to $63.22 in 2025.
- Its last three reported values are $63.22 in Q3 2025, $56.07 for Q1 2025, and $0.07 during Q1 2024.